March 06, 2015 1:34 PM ET

Pharmaceuticals

Company Overview of Oxford GlycoSciences Plc

Company Overview

As of July 17, 2003, Oxford GlycoSciences Plc was acquired by Celltech Group plc. Oxford GlycoSciences Plc operates as a biopharmaceutical company applying proteomics technologies and glycobiology to the discovery, development, and commercialisation of novel therapeutic products. Its drug discovery efforts focus on three main therapeutic areas: cancer, anti-infective, and glycolipid storage disorders. The company is headquartered at Abingdon, United Kingdom with an additional office in Oxfordshire, United Kingdom.

The Forum

86 Milton Park

Abingdon,  OX14 4RY

United Kingdom

Fax:

44 12 3520 8020

Key Executives for Oxford GlycoSciences Plc

Oxford GlycoSciences Plc does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Acron Genomics Inc. Europe
Ipsen Developments Limited Europe
Antiva Therapeutics Limited Europe
Vifor Pharma UK Limited Europe
Glaxo Operations UK Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oxford GlycoSciences Plc, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.